Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. 2013

Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
Department of Radiobiology and Immunology, Institute of Biology, Jan Kochanowski University, Kielce, Poland. alankoff@gmail.com

Silica nanoparticles have an interesting potential in drug delivery, gene therapy and molecular imaging due to the possibility of tailoring their surface reactivity that can be obtained by surface modification. Despite these potential benefits, there is concern that exposure of humans to certain types of silica nanomaterials may lead to significant adverse health effects. The motivation of this study was to determine the kinetics of cellular binding/uptake of the vinyl- and the aminopropyl/vinyl-modified silica nanoparticles into peripheral blood lymphocytes in vitro, to explore their genotoxic and cytotoxic properties and to compare the biological properties of modified silica nanoparticles with those of the unmodified ones. Size of nanoparticles determined by SEM varied from 10 to 50 nm. The average hydrodynamic diameter and zeta potential also varied from 176.7 nm (+18.16 mV) [aminopropyl/vinyl-modified] and 235.4 nm (-9.49 mV) [vinyl-modified] to 266.3 (-13.32 mV) [unmodified]. Surface-modified silica particles were internalized by lymphocytes with varying efficiency and expressed no cytotoxic nor genotoxic effects, as determined by various methods (cell viability, apoptosis/necrosis, oxidative DNA damage, chromosome aberrations). However, they affected the proliferation of the lymphocytes as indicated by a decrease in mitotic index value and cell cycle progression. In contrast, unmodified silica nanoparticles exhibited cytotoxic and genotoxic properties at high doses as well as interfered with cell cycle.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin

Related Publications

Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
October 2014, Molecular pharmaceutics,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
August 2019, International journal of molecular sciences,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
August 2015, Cell biology international,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
August 2017, Cytotechnology,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
January 2023, Current research in immunology,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
August 2011, Nanoscale,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
June 2019, Journal of biochemical and molecular toxicology,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
September 2014, Nanoscale,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
July 2019, Journal of applied toxicology : JAT,
Anna Lankoff, and Michal Arabski, and Aneta Wegierek-Ciuk, and Marcin Kruszewski, and Halina Lisowska, and Anna Banasik-Nowak, and Krystyna Rozga-Wijas, and Maria Wojewodzka, and Stanislaw Slomkowski
August 2018, Biological trace element research,
Copied contents to your clipboard!